A groundbreaking study reveals that the drug LL-341070 could help repair myelin damage, offering hope for vision restoration ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

TG Therapeutics said it is working to develop a subcutaneous (under-the-skin) version of relapsing MS therapy Briumvi.

A new study by UC San Francisco has found that menopause revs up the progression of multiple sclerosis (MS ... increased degeneration of nerve cells – a hallmark of advancing MS – and ...

Background A growing evidence base supports the use of autologous haematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS), but it has not yet ...

Early signs of multiple sclerosis can include blurry vision, muscle weakness, dizziness and fatigue, and unusual tingling or pain sensations. These early warning signs occur because of damage to the ...

Multiple sclerosis (MS) is a chronic condition affecting the central nervous system. Its symptoms range from mild and intermittent to severe and permanently damaging. There’s currently no cure ...

Multiple sclerosis (MS) is a chronic inflammatory disease of the ... Patients with MS exhibit impaired regulatory T cell populations, and both Foxp3+ Tregs and type I regulatory T cells (Tr1) are ...